Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Alnylam Pharmaceuticals Inc | 1,334 |
| 2 | Novartis AG | 1,154 |
| 3 | Fujifilm Holdings Corp | 1,152 |
| 4 | Samsung Biologics Co Ltd | 979 |
| 5 | Roche Holding AG | 960 |
| 6 | University of California | 909 |
| 7 | Ionis Pharmaceuticals Inc | 856 |
| 8 | Merck and Co Inc | 837 |
| 9 | GSK PLC | 802 |
| 10 | Takeda Pharmaceutical Co Ltd | 634 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 54,974 |
| 2 | A61P | Therapeutic activity (drug indications) | 49,146 |
| 3 | C07K | Peptides | 24,680 |
| 4 | C12N | Microorganisms, enzymes | 23,909 |
| 5 | G01N | Investigating / analysing materials | 14,058 |
| 6 | C07D | Heterocyclic compounds | 8,654 |
| 7 | C12Q | Measuring/testing involving enzymes | 8,486 |
| 8 | Y02A | Climate change adaptation | 6,042 |
| 9 | Y10S | Cross-reference (legacy) | 3,990 |
| 10 | C12Y | Enzyme nomenclature (EC numbers) | 3,716 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Process for preparing 3alpha(beta)-7alpha(beta)-dihydroxy-6alpha(beta)-alkyl-5beta-cholanic acid | 2008 | Alfasigma SpA | 63 |
| 3alpha, 9alpha-epoxy steroids of the androstane and pregnane series | 1962 | Pfizer Inc | 31 |
| Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits | 2014 | AbbVie Inc | 29 |
| Formulations of deoxycholic acid and salts thereof | 2013 | AbbVie Inc | 25 |
| Formulations of deoxycholic acid and salts thereof | 2012 | AbbVie Inc | 25 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 96 |
| 2017 | 123 |
| 2018 | 97 |
| 2019 | 107 |
| 2020 | 86 |
| 2021 | 74 |
| 2022 | 61 |
| 2023 | 54 |
| 2024 | 59 |
| 2025 | 32 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Youngro Byun | Seoul National University | 36 |
| 2 | Alan F. Hofmann | University of California San Diego | 27 |
| 3 | Junichi Goto | Tohoku University | 15 |
| 4 | Harris Bernstein | University of Arizona | 14 |
| 5 | Carol Bernstein | University of Arizona | 12 |
| 6 | Aldo Roda | University of Bologna | 10 |
| 7 | R. H. Dowling | Guy's Hospital | 10 |
| 8 | Hyun Tae Moon | GS Caltex (South Korea) | 9 |
| 9 | U. Leuschner | Goethe University Frankfurt | 9 |
| 10 | Thomas A. Miller | Virginia Commonwealth University Medical Center | 8 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Assay of proteins in the presence of interfering materials | 1976 | 3207 | Mass Spectrometry Techniques and Applications |
| Solubilization of membranes by detergents | 1975 | 2943 | Lipid Membrane Structure and Behavior |
| Identification of a Nuclear Receptor for Bile Acids | 1999 | 2703 | Drug Transport and Resistance Mechanisms |
| Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome | 2013 | 2216 | Gut microbiota and health |
| lincRNAs act in the circuitry controlling pluripotency and differentiation | 2011 | 1908 | MicroRNA in disease regulation |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of Deoxycholic Acid?
Which organizations have the most patents related to Deoxycholic Acid?
Who are the most prolific researchers publishing on Deoxycholic Acid?
What are the primary patent classification areas for Deoxycholic Acid inventions?
How has research publication activity on Deoxycholic Acid changed over recent years?